Showing results (51-60 of 299) with videos related to
Sort By:
Pageof 30
Cancer Treatment and Research Communications|November 25, 2022
Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancerJacqueline V Aredo, Heather A Wakelee, Angela Bik-Yu Hui, et al.Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Circulating tumor DNA testing in advanced non-small cell lung cancerEverett J Moding, Maximilian Diehn, Heather A WakeleeHematology/Oncology Clinics of North America|December 4, 2016
Neoadjuvant and Adjuvant Therapy for Non-Small Cell Lung CancerJody C Chuang, Ying Liang, Heather A WakeleeImmunopharmacology and Immunotoxicology|February 6, 2014
Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung cancer patientsJonathan W Riess, Nupur Bhattacharya, Kim R M Blenman, et al.Journal of Global Oncology|November 14, 2018
Comparison of Genomic Driver Oncogenes in Vietnamese Patients With Non-Small-Cell Lung Cancer in the United States and VietnamKim-Son H Nguyen, Henning Stehr, Li Zhou, et al.JTO Clinical and Research Reports|January 27, 2025
Afatinib and Necitumumab in EGFR-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase InhibitorsNathaniel J Myall, Jennifer G Whisenant, Joel W Neal, et al.JTO Clinical and Research Reports|November 19, 2025
DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed EGFR-Mutant Lung Cancer and Two Cases of Tarlatamab TherapyJacqueline V Aredo, Surbhi Singhal, Gerald J Berry, et al.Journal of the National Cancer Institute|December 11, 2021
The Survival Impact of Second Primary Lung Cancer in Patients With Lung CancerEunji Choi, Sophia J Luo, Jacqueline V Aredo, et al.Expert Opinion on Pharmacotherapy|March 8, 2016
Rociletinib, a third generation EGFR tyrosine kinase inhibitor: current data and future directionsJody C Chuang, Ameen A Salahudeen, Heather A WakeleeClinical Lung Cancer|July 28, 2006
Lung cancer in women: exploring sex differences in susceptibility, biology, and therapeutic responseJessica S Donington, Quynh-Thu Le, Heather A WakeleePageof 30